fluconazole has been researched along with Vaginitis in 18 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Vaginitis: Inflammation of the vagina characterized by pain and a purulent discharge.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, the authors observed the clinical efficacy of Sophora gel combined with Fluconazole capsules in treating mycotic vaginitis, in order to seek an effective method for treating mycotic vaginitis." | 6.80 | [Clinical observation on treatment of mycotic vaginitis with Sophora gel combined with Fluconazole capsules]. ( Cui, L; Ma, CF; Wang, HX; Wang, NM, 2015) |
| "In this study, oral administration of the triazole D0870 was compared to oral administration of fluconazole in the treatment of experimental vaginal candidiasis." | 3.69 | Efficacy of D0870 treatment of experimental Candida vaginitis. ( Cutright, JL; Fidel, PL; Sobel, JD, 1997) |
| " In this study, the authors observed the clinical efficacy of Sophora gel combined with Fluconazole capsules in treating mycotic vaginitis, in order to seek an effective method for treating mycotic vaginitis." | 2.80 | [Clinical observation on treatment of mycotic vaginitis with Sophora gel combined with Fluconazole capsules]. ( Cui, L; Ma, CF; Wang, HX; Wang, NM, 2015) |
| " The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González, GM | 1 |
| Robledo, E | 1 |
| Garza-González, E | 1 |
| Elizondo, M | 1 |
| González, JG | 1 |
| Jin, L | 1 |
| Bai, X | 1 |
| Luan, N | 1 |
| Yao, H | 1 |
| Zhang, Z | 1 |
| Liu, W | 1 |
| Chen, Y | 1 |
| Yan, X | 1 |
| Rong, M | 1 |
| Lai, R | 1 |
| Lu, Q | 1 |
| Adler, NR | 1 |
| Lin, MJ | 1 |
| Cameron, R | 1 |
| Gin, D | 1 |
| Donders, GGG | 1 |
| Grinceviciene, S | 1 |
| Bellen, G | 1 |
| Jaeger, M | 1 |
| Ten Oever, J | 1 |
| Netea, MG | 1 |
| Esposito, E | 1 |
| Campolo, M | 1 |
| Casili, G | 1 |
| Lanza, M | 1 |
| Filippone, A | 1 |
| Peritore, AF | 1 |
| Cuzzocrea, S | 1 |
| De Bernardis, F | 2 |
| Arancia, S | 1 |
| Tringali, G | 1 |
| Greco, MC | 1 |
| Ragazzoni, E | 1 |
| Calugi, C | 1 |
| Trabocchi, A | 1 |
| Sandini, S | 1 |
| Graziani, S | 1 |
| Cauda, R | 1 |
| Cassone, A | 2 |
| Guarna, A | 1 |
| Navarra, P | 1 |
| González-Fernández, T | 1 |
| López-Freire, S | 1 |
| Juangorena, M | 1 |
| Méndez-Brea, P | 1 |
| Vázquez-Veiga, H | 1 |
| Wang, NM | 1 |
| Cui, L | 1 |
| Ma, CF | 1 |
| Wang, HX | 1 |
| Yang, L | 1 |
| Su, MQ | 1 |
| Ma, YY | 1 |
| Xin, YJ | 1 |
| Han, RB | 1 |
| Zhang, R | 1 |
| Wen, J | 1 |
| Hao, XK | 1 |
| Kairon, R | 1 |
| Godbole, S | 1 |
| Kulkarni, S | 1 |
| Ghate, M | 1 |
| Sane, S | 1 |
| Mehendale, S | 1 |
| Risbud, A | 1 |
| Shrotri, A | 1 |
| Bharucha, K | 1 |
| Naidu, AS | 1 |
| Fowler, RS | 1 |
| Martinez, C | 1 |
| Chen, J | 1 |
| Tulpinski, J | 1 |
| Ranganathan, S | 1 |
| Moosa, F | 1 |
| Kamarulzaman, A | 1 |
| Looi, LM | 1 |
| Sharma, JB | 1 |
| Mittal, S | 1 |
| Raina, U | 1 |
| Chanana, C | 1 |
| Savini, V | 1 |
| Catavitello, C | 1 |
| Manna, A | 1 |
| Talia, M | 1 |
| Febbo, F | 1 |
| Balbinot, A | 1 |
| D'Antonio, F | 1 |
| Di Bonaventura, G | 1 |
| Celentano, C | 1 |
| Liberati, M | 1 |
| Piccolomini, R | 1 |
| D'Antonio, D | 1 |
| Fidel, PL | 1 |
| Cutright, JL | 1 |
| Sobel, JD | 1 |
| Zhang, H | 1 |
| Lu, Y | 1 |
| Liang, D | 1 |
| Beninati, C | 1 |
| Oggioni, MR | 1 |
| Boccanera, M | 1 |
| Spinosa, MR | 1 |
| Maggi, T | 1 |
| Conti, S | 1 |
| Magliani, W | 1 |
| Teti, G | 1 |
| Pozzi, G | 1 |
| Polonelli, L | 1 |
| Czaika, V | 1 |
| Tietz, HJ | 1 |
| Schmalreck, A | 1 |
| Sterry, W | 1 |
| Schultze, W | 1 |
1 review available for fluconazole and Vaginitis
| Article | Year |
|---|---|
Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Diagnosis, Differential; Drug Resistance, Funga | 2008 |
3 trials available for fluconazole and Vaginitis
| Article | Year |
|---|---|
[Clinical observation on treatment of mycotic vaginitis with Sophora gel combined with Fluconazole capsules].
Topics: Adult; Antifungal Agents; Capsules; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Flucon | 2015 |
Comparative efficacy of two regimens in syndromic management of lower genital infections.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Azithromycin; Clotrimazole; Drug | 2006 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
14 other studies available for fluconazole and Vaginitis
| Article | Year |
|---|---|
Efficacy of albaconazole against Candida albicans in a vaginitis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Female; Fluconazole; Mice; Mice, | 2009 |
A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis.
Topics: Animals; Antimicrobial Cationic Peptides; Arginine; Candida albicans; Dose-Response Relationship, Dr | 2016 |
Fluconazole-induced Sweet's syndrome: A novel association.
Topics: Biopsy, Needle; Candidiasis; Diagnosis, Differential; Drug Eruptions; Female; Fluconazole; Humans; I | 2018 |
Is non-response to fluconazole maintenance therapy for recurrent Candida vaginitis related to sensitization to atopic reactions?
Topics: Adult; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Hypersensitivity, I | 2018 |
Effect of pea protein plus grape seed dry extract on a murine model of Candida albicans induced vaginitis.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Vulvovaginal; Disease Models, A | 2018 |
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis.
Topics: Animals; Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Caspofungin; Che | 2014 |
Herpes-like eruption due to fluconazole.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Fluconazole; Herpesvirida | 2015 |
Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fun | 2016 |
Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; HIV Sero | 2004 |
Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Topics: Analysis of Variance; Antifungal Agents; Candida albicans; Candida glabrata; Drug Interactions; Fema | 2004 |
MRI and CT findings of cryptococcal vaginitis.
Topics: Adult; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Magnetic Resonance Imaging; T | 2005 |
Efficacy of D0870 treatment of experimental Candida vaginitis.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Mice; Mice | 1997 |
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria.
Topics: Administration, Intravaginal; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agen | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Flucon | 2000 |